Human Endogenous Retroviruses and Toll-Like Receptors

Viral Immunol. 2023 Mar;36(2):73-82. doi: 10.1089/vim.2022.0090. Epub 2022 Oct 13.

Abstract

Human endogenous retroviruses (HERVs) are estimated to comprise ∼8% of the entire human genome, but the vast majority of them remain transcriptionally silent in most normal tissues due to accumulated mutations. However, HERVs can be frequently activated and detected in various tissues under certain conditions. Nucleic acids or proteins produced by HERVs can bind to pattern recognition receptors of immune cells or other cells and initiate an innate immune response, which may be involved in some pathogenesis of diseases, especially cancer and autoimmune diseases. In this review, we collect studies of the interaction between HERV elements and Toll-like receptors and attempt to provide an overview of their role in the immunopathological mechanisms of inflammatory and autoimmune diseases.

Keywords: Toll-like receptors; human endogenous retroviruses; innate immunity.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoimmune Diseases*
  • Endogenous Retroviruses* / genetics
  • Humans
  • Immunity, Innate
  • Neoplasms*
  • Toll-Like Receptors / genetics

Substances

  • Toll-Like Receptors